ArticleAging2021
Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain.
Ting Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleAging2021
Ting Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.